Compare · HLN vs PHH
HLN vs PHH
Side-by-side comparison of Haleon plc (HLN) and Park Ha Biological Technology Co. Ltd. (PHH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HLN and PHH operate in Package Goods/Cosmetics (Consumer Discretionary), so they compete in similar markets.
- HLN carries a market cap of $40.61B.
- Over the past year, HLN is down 16.0% and PHH is down 97.9% - HLN leads by 81.9 points.
- HLN has hit the wire 12 times in the past 4 weeks while PHH has been quiet.
- HLN has more recent analyst coverage (19 ratings vs 0 for PHH).
- Company
- Haleon plc
- Park Ha Biological Technology Co. Ltd.
- Price
- $9.14+0.22%
- $0.38-0.29%
- Market cap
- $40.61B
- -
- 1M return
- +1.78%
- -23.43%
- 1Y return
- -15.99%
- -97.94%
- Industry
- Package Goods/Cosmetics
- Package Goods/Cosmetics
- Exchange
- NYSE
- NASDAQ
- IPO
- 2022
- 2024
- News (4w)
- 12
- 0
- Recent ratings
- 19
- 0
Haleon plc
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom. Haleon plc(LSE:HLN) operates independently of GSK plc as of July 18, 2022.
Latest HLN
- Advil Challenges Sports Culture's "No Pain No Gain" Mentality This Summer
- SEC Form 6-K filed by Haleon plc
- Haleon Invests in India to Deliver Better Everyday Health to Rural Communities
- Haleon Issues Voluntary Nationwide Recall of Gas-X Extra Strength Softgels 125mg, 120 ct. and 72 ct.
- TUMS Kicks Off the "TUMS Food Match Cup," a Celebration of Global Soccer Fandom and Food Love Through Bold Flavor Mashups
- SEC Form 6-K filed by Haleon plc
- SEC Form 6-K filed by Haleon plc
- SEC Form SD filed by Haleon plc
- SEC Form 6-K filed by Haleon plc
- SEC Form 6-K filed by Haleon plc
Latest PHH
- Park Ha Biological Technology Co., Ltd. Announces Closing of a US$2.45 Million Public Offering
- Park Ha Biological Technology Co., Ltd. Announces Pricing of US$2.45 Million Best-Efforts Follow-on Public Offering
- SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.
- Park Ha Biological Technology Co., Ltd. Announces Nasdaq Ticker Symbol Change to BYAH
- SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.
- Amendment: SEC Form F-1/A filed by Park Ha Biological Technology Co. Ltd.
- SEC Form F-1 filed by Park Ha Biological Technology Co. Ltd.
- SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.
- SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.
- SEC Form 6-K filed by Park Ha Biological Technology Co. Ltd.